NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $59.6M
1-Year Est. Return 40.02%
This Quarter Est. Return
1 Year Est. Return
+40.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$63.4M
AUM Growth
-$59.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
35
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$9.4M
2
+$9.17M
3
+$6.61M
4
PTGX icon
Protagonist Therapeutics
PTGX
+$5.87M
5
SLNO icon
Soleno Therapeutics
SLNO
+$5.69M

Sector Composition

1 Healthcare 99.82%
2 Materials 0.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALV icon
26
KalVista Pharmaceuticals
KALV
$662M
– –
-154,522
MIRM icon
27
Mirum Pharmaceuticals
MIRM
$3.56B
– –
-146,765
MRUS icon
28
Merus
MRUS
$7.29B
– –
-120,038
PTGX icon
29
Protagonist Therapeutics
PTGX
$5.2B
– –
-121,400
SLNO icon
30
Soleno Therapeutics
SLNO
$2.54B
– –
-79,650
TRML
31
DELISTED
Tourmaline Bio
TRML
– –
-227,090
VRNA
32
DELISTED
Verona Pharma
VRNA
– –
-147,990
XENE icon
33
Xenon Pharmaceuticals
XENE
$3.09B
– –
-158,605
ZLAB icon
34
Zai Lab
ZLAB
$2.4B
– –
-253,675
CLYM
35
Climb Bio
CLYM
$128M
– –
-463,654
1
2